SCI时时刷

search
+
The impact of the implementation of computerized insulin order sets for the control of hyperglycemia in hospitalized cardiac patients
The impact of the implementation of computerized insulin order sets for the control of hyperglycemia in hospitalized cardiac patients
Background Glycemic control is crucial in managing hospitalized patients with type II diabetes (T
Chronic GLP1 therapy reduces postprandial IL6 in obese humans with prediabetes
Chronic GLP1 therapy reduces postprandial IL6 in obese humans with prediabetes
Single-dose glucagon-like peptide 1 (GLP1) therapy increases postprandial plasma IL6 levels in predi
Thyroid dysfunction and mortality in cardiovascular hospitalized patients
Thyroid dysfunction and mortality in cardiovascular hospitalized patients
Background Thyroid dysfunction (TD) is associated with increased cardiovascular morbidity and mor
Unexpected case of Graves` disease induced myocarditis: a case report
Unexpected case of Graves` disease induced myocarditis: a case report
Myocarditis due to Graves` disease is rare and has a clinical presentation that mimics acute coronar
A population-based study on hyperinsulinaemia and arterial stiffness in men with and without abdominal aortic aneurysm
A population-based study on hyperinsulinaemia and arterial stiffness in men with and without abdominal aortic aneurysm
Objectives Patients with type 2 diabetes mellitus (DM) run lower risk for abdominal aortic aneury
The concomitant use of sodium-glucose co-transporter 2 inhibitors improved the renal outcome of Japanese patients with type 2 diabetes treated with glucagon-like peptide 1 receptor agonists
The concomitant use of sodium-glucose co-transporter 2 inhibitors improved the renal outcome of Japanese patients with type 2 diabetes treated with glucagon-like peptide 1 receptor agonists
Aims This study aimed to clarify the renal influence of glucagon-like peptide 1 receptor agonists
Success story of GLP-1 agonist (Liraglutide) treatment in someone with type 1 diabetes: a life transformed
Success story of GLP-1 agonist (Liraglutide) treatment in someone with type 1 diabetes: a life transformed
Background Glucagon-like peptide-1 (GLP-1) agonists are now widely used for the treatment of type 2 diabetes (T...
A 5-structured visits multidisciplinary clinical care approach to optimize the care of patients with type 2 diabetes: a pilot study
A 5-structured visits multidisciplinary clinical care approach to optimize the care of patients with type 2 diabetes: a pilot study
Introduction Multidisciplinary coordinated care has been associated with improvement of diabetes
The role of polycystic ovary syndrome in preclinical left ventricular diastolic dysfunction: an echocardiographic approach: a systematic review and meta-analysis
The role of polycystic ovary syndrome in preclinical left ventricular diastolic dysfunction: an echocardiographic approach: a systematic review and meta-analysis
Background Polycystic ovary syndrome (PCOS) is a common endocrine disorder affecting women of chi
Association between right heart catheterization hemodynamics and glycosylated hemoglobin levels in adults with heart failure with reduced ejection fraction
Association between right heart catheterization hemodynamics and glycosylated hemoglobin levels in adults with heart failure with reduced ejection fraction
Background This study hypothesized that elevated glycosylated hemoglobin (HbA1c) levels are assoc
First episode psychosis and weight gain a longitudinal perspective in Cheshire UK: a comparison between individuals with nonaffective versus affective psychosis
First episode psychosis and weight gain a longitudinal perspective in Cheshire UK: a comparison between individuals with nonaffective versus affective psychosis
Introduction Early weight gain following initiation of antipsychotic treatment predicts longer-te
Combined lactic acidosis and ketoacidosis in a female diabetic patient with severe heart failure
Combined lactic acidosis and ketoacidosis in a female diabetic patient with severe heart failure
SGLT2i are now recommended in a wide spectrum of indications including type 2 diabetes (T2DM), heart
Cardiovascular parameters following parathyroidectomy in primary hyperparathyroidism: a systematic review and meta-analysis
Cardiovascular parameters following parathyroidectomy in primary hyperparathyroidism: a systematic review and meta-analysis
Introduction There is conflicting evidence on the benefits of parathyroidectomy (PTx) in reducing
Mineralocorticoid receptor antagonists in cardiovascular translational biology
Mineralocorticoid receptor antagonists in cardiovascular translational biology
This review examines the role of mineralocorticoid receptor antagonists (MRAs) in cardiovascular bio
Takotsubo syndrome with several hypertensive crises: an unexpected diagnosis
Takotsubo syndrome with several hypertensive crises: an unexpected diagnosis
We present an unusual clinical case of a 39-year-old woman admitted to the Department of Cardiology
Enhancing type 2 diabetes treatment through digital plans of care. Patterns of access to a care-planning app over the first 3 months of a digital health intervention
Enhancing type 2 diabetes treatment through digital plans of care. Patterns of access to a care-planning app over the first 3 months of a digital health intervention
The increasing digitalization of healthcare brings opportunities to enable much greater patient access to evidence-based i...
Safety outcomes of sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes and other risk factors for cardiovascular disease: a systematic review and meta-analysis
Safety outcomes of sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes and other risk factors for cardiovascular disease: a systematic review and meta-analysis
Introduction Sodium-glucose cotransporter-2 inhibitors (SGLT2-Is) have emerged as standard therap
Cardiometabolic syndrome in HIV-positive and HIV-negative patients at Zewditu Memorial Hospital, Addis Ababa, Ethiopia: a comparative cohort study
Cardiometabolic syndrome in HIV-positive and HIV-negative patients at Zewditu Memorial Hospital, Addis Ababa, Ethiopia: a comparative cohort study
Background Cardiometabolic syndrome (CMetS) has recently emerged as a serious public health conce
Does food responsiveness change in people with first-episode psychosis over a period of 3 months after commencing antipsychotics? Preliminary results
Does food responsiveness change in people with first-episode psychosis over a period of 3 months after commencing antipsychotics? Preliminary results
Weight gain occurs in many patients with schizophrenia [1], a diagnosis often subsequently made in individuals who first p...
Real-world demographic patterns of users of a digital primary prevention service for diabetes
Real-world demographic patterns of users of a digital primary prevention service for diabetes
Background Rapid urbanization has led to an exponential increase in lifestyle-associated metaboli
Type 2 diabetes and mortality in females versus males in England: the Salford diabetes cohort
Type 2 diabetes and mortality in females versus males in England: the Salford diabetes cohort
Diabetes continues to be linked to a mortality rate that is greater than the background population. A previous study based...
Relationship between the triglyceride-glucose index and the SYNTAX score 2 in patients with non-ST elevation myocardial infarction
Relationship between the triglyceride-glucose index and the SYNTAX score 2 in patients with non-ST elevation myocardial infarction
Objective We evaluated if admissiontriglyceride-glucose index (TyG index) correlated with the ana
The association between a genetic variant in the SULF2 gene, metabolic parameters and vascular disease in patients at high cardiovascular risk
The association between a genetic variant in the SULF2 gene, metabolic parameters and vascular disease in patients at high cardiovascular risk
Background Clearance of triglyceride-rich lipoproteins (TRLs) is mediated by several receptors, i
Prioritizing obesity treatment: expanding the role of cardiologists to improve cardiovascular health and outcomes
Prioritizing obesity treatment: expanding the role of cardiologists to improve cardiovascular health and outcomes
Obesity is a major risk factor for cardiovascular disease, yet management remains poor. Cardiologist
Cardiac autonomic neuropathy linked to left ventricular dysfunction in type 1 diabetic patients
Cardiac autonomic neuropathy linked to left ventricular dysfunction in type 1 diabetic patients
Introduction Type 1 diabetes is a major cause of cardiovascular death; diabetic cardiomyopathy (D
Response to the report published by the UK House of Commons All-Party Parliamentary Group on Chronic Fatigue Syndrome/Myalgic Encephalitis (CFS/ME): implications for cardiometabolic risk
Response to the report published by the UK House of Commons All-Party Parliamentary Group on Chronic Fatigue Syndrome/Myalgic Encephalitis (CFS/ME): implications for cardiometabolic risk
Chronic Fatigue Syndrome/Myalgic Encephalitis (CFS/ME) is associated with affected individuals being more sedentary and ha...
National level prescribing of psychotropic medication in primary care during the COVID-19 pandemic in England: potential implications for cardiometabolic health
National level prescribing of psychotropic medication in primary care during the COVID-19 pandemic in England: potential implications for cardiometabolic health
The COVID-19 (SARS-CoV-2) pandemic has had a global impact on healthcare provision. Changes in prescribing of commonly use...
Glucose dysregulation and repolarization variability markers are short-term mortality predictors in decompensated heart failure
Glucose dysregulation and repolarization variability markers are short-term mortality predictors in decompensated heart failure
Objective As recently reported, elevated fasting glucose plasma level constitutes a risk factor f
A retrospective real-world observational pilot analysis of Waya: a self-monitoring fitness app in Germany
A retrospective real-world observational pilot analysis of Waya: a self-monitoring fitness app in Germany
Background The increasing prevalence of lifestyle-driven metabolic disorders poses a heavy burden
Can glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors help in mitigating the risk of atrial fibrillation in patients with diabetes?
Can glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors help in mitigating the risk of atrial fibrillation in patients with diabetes?
The role of glucagon-like peptide-1 receptor agonists (GLP-1 RA) and dipeptidyl peptidase-4 inhibito
阅读更多
format_indent_increase